Meningitis | eHealth News | Page 5

The U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has voted to issue a category B recommendation for use of two serogroup B meningococcal vaccines in patients aged 16 to 23 years for short-term disease prevention

ACIP Recommends MenB Vaccine for 16- to 23-Year-Olds

HealthDay.com - Jul 8, 2015 0

Category B recommendation for short-term protection against meningitis for all aged 16 to 23

An investigational serogroup B meningococcal vaccine seems to have protected vaccinated individuals from the disease during an outbreak

Investigational MenB Vaccine Can Protect Individuals in Outbreak

HealthDay.com - Apr 30, 2015 0

No serogroup B meningococcal disease cases in those who received MenB vaccine in university outbreak

The Bexsero vaccine has been approved by the U.S. Food and Drug Administration to prevent serogroup B meningococcal disease among people aged 10 through 25.

FDA Approves New Meningococcal Disease Vaccine

HealthDay.com - Jan 26, 2015 0

Bexsero is the second vaccine approved in the past three months to prevent this disease

1...3 45Page 5 of 5

Archives